Media Coverage

Genomic Vision (Paris:GV) (FR0011799907 - GV), a company specialized in the development of in-vitro diagnostic (IVD) tests for the early detection of cancers and genetic diseases and applications for life sciences research (LSR), today announced its revenue and cash position1 at March 31, 2019. First quarter 2019 revenue In € thousands Q1 2019 Q1 2018 Revenue from R&D collaboration with Quest Diagnostics 75 75 Sales of products and

With the recent formation of the Get the Medications Right (GTMRx) Institute, Quest Diagnostics and the other institute co-founders aim to drive the use of advanced diagnostics for guiding patient treatment.[CR-LF][CR-LF]Launched this month by organizations including J&J, Medecision, and the American College of Clinical Pharmacy, the institute will function "as an advocacy entity" for companion diagnostics and pharmacogenomic testing, said Steve Goldberg, vice president, medical affairs, population health and chief health officer, health and wellness at Quest, and a member of the GTMRx board.

Changes in state laws regarding the treatment of marijuana, which are in direct conflict with federal law, have raised concerns and caused confusion among employers and employees regarding standards for drug-free workplaces and employment drug testing procedures and programs. An Arizona US District Judge is the latest to weigh in on the matter—ruling on the side of a Walmart worker who had been fired after failing a company drug test.[CR-LF][CR-LF]US employers are feeling the impact of liberalized marijuana laws, according to employment drug testing performed by Quest Diagnostics, a leading provider of diagnostic information services.

One day after the Texas House overwhelmingly voted to virtually decriminalize the possession of small amounts of marijuana for first-time offenders, the president of the Texas Senate effectively drove a stake through the heart of the measure.[CR-LF][CR-LF]"I join with those House Republicans who oppose this step toward legalization of marijuana," Lt. Gov. Dan Patrick said in a tweet Tuesday morning. Marijuana use is on the rise among US workers, a study from Quest Diagnostics found, increasing by 16% since 2014.

An alliance of independent health systems across Massachusetts has expanded from three to 10 organizations, enabling them to leverage cheaper contracts while maintaining their autonomy.[CR-LF][CR-LF]The Massachusetts Value Alliance, which initially formed in 2016, is a collaboration of 14 hospitals in the state that work together on group purchasing contracts and share best practices in order to be competitive in their market while still remaining independent. The combined health systems serve about 2 million people. Since the Massachusetts alliance formed three years ago, the organizations have worked together to negotiate on lab referral contracts. The members waited until their contracts were up and decided to go forward with one contract with Quest Diagnostics.

More U.S. workers are testing positive for marijuana while the number testing positive for opioids continues to decline, according to the annual Quest Diagnostics Drug Testing Index.[CR-LF][CR-LF]Based on an analysis of nine million drug tests conducted in 2018, Quest determined that 5.1 percent of the general workforce tested positive for drugs and another 2.7 percent of workers in safety-sensitive positions regulated by federal law did so. Those in safety-sensitive jobs include pilots; rail, bus and truck drivers; and workers in nuclear power plants.

As hospitals turn to technology to overhaul the patient experience and improve profits, a range of vendors from are bring new products and outsourced services to meet that demand with artificial intelligence, data analytics and natural language processing as well as cognitive and process automation.The end-to-end solution may not work for every system, but all providers are looking to modernize. Some do it through Optum products such as computer assisted coding technologies with natural language processing baked in.[CR-LF][CR-LF]Using partner Quest Diagnostics, Optum360 can predict patient responsibility at the point of service.

As attorneys argued over a section of an Arizona law that differentiates between marijuana and cannabis, the state’s Supreme Court justices joked about baking pot brownies in their kitchens.[CR-LF][CR-LF]They clearly do not understand how the marijuana industry has irresponsibly manipulated pot into dangerously high levels of potency.[CR-LF]Marijuana use is on the rise among US workers, a study from Quest Diagnostics found, increasing by 16% since 2014.

Major testing lab Quest Diagnostics says a small proportion of workforce tests nationally come back positive for marijuana or any other drugs, but the number has been growing in recent years.[CR-LF][CR-LF]Including job applicants and hired workers, the positive-test rate for marijuana was 2.8% last year, up from 2.4% in 2014, the Secaucus, New Jersey-based company said Thursday.

UnitedHealthcare this week named seven labs to its new Preferred Laboratory Network. They are AmeriPath/DermPath, a division of Quest Diagnostics; BioReference and its GeneDx lab; Invitae; Laboratory Corporation of America; Mayo Clinic Laboratories; and Quest. PLN's goal is threefold: to make healthcare affordable, improve outcomes, and improve the patient experience, UHC said in a statement. PLN launches on July 1, 2019. While UHC customers can choose a lab not in PLN, the price of services accessed through the network will be lower, UHC said, noting that pathology services for a biopsy in PLN would be $90 compared to $150 outside of PLN.